En | De
No articles selected!     View Cart  
You are here: Oncology » Gynecologic Neoplasms 22. January 2022
Gynecologic Neoplasms
Advanced search
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Musculoskeletal System
Endocrine System
Gynecologic Neoplasms
Respiratory Tract
Urologic Neoplasms
Respiratory Tract
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 12655  Previews Next
   Articles 1 - 20 / 253099  
Rising Circulating Tumor DNA As a Molecular Biomarker of Early Disease Progression in Metastatic Breast Cancer.
JCO Precis Oncol
Velimirovic M, Juric D, Niemierko A, Spring L, Vidula N, Wander SA, Medford A, Parikh A, Malvarosa G, Yuen M, Corcoran R, Moy B, Isakoff SJ, Ellisen LW, Iafrate A, Chabner B, Bardia A.
PMID: 35050782 [PubMed - as supplied by publisher]

Circulating Tumor DNA and Biomarker Analyses From the LOTUS Randomized Trial of First-Line Ipatasertib and Paclitaxel for Metastatic Triple-Negative Breast Cancer.
JCO Precis Oncol
Wongchenko MJ, Kim SB, Saura C, Oliveira M, Lipson D, Kennedy M, Greene M, Breese V, Mani A, Xu N, Dent R.
PMID: 35050767 [PubMed - as supplied by publisher]

Concerns About Methods Used in Modeling Study of Risk-Stratified Screening for Breast Cancer.
JAMA Oncol
Pashayan N, Pharoah PDP.
PMID: 35050325 [PubMed - as supplied by publisher]

Errors in the Calculation Used to Estimate Number of Overdiagnoses in Study of Risk-Stratified Screening for Breast Cancer.
JAMA Oncol

PMID: 35050316 [PubMed - as supplied by publisher]

Safety Profile of Niraparib as Maintenance Therapy for Ovarian Cancer: A Systematic Review and Meta-Analysis.
Curr Oncol
Pagkali A, Mamais I, Michalinos A, Agouridis AP.
PMID: 35049703 [PubMed - as supplied by publisher]

Immune Effective Score as a Predictor of Response to Neoadjuvant Trastuzumab Therapy and a Prognostic Indicator for HER2-Positive Breast Cancer.
Curr Oncol
Wu X, Zhang C, Zhang H.
PMID: 35049700 [PubMed - as supplied by publisher]

Neoadjuvant and Adjuvant Systemic Therapy for Newly Diagnosed Stage II-IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma: A Practice Guideline.
Curr Oncol
Hirte H, Poon R, Yao X, May T, Ethier JL, Petz L, Speakman J, Elit L.
PMID: 35049696 [PubMed - as supplied by publisher]

Relationship between Breast Cancer Surgical Treatment and Psychiatric Symptomatology: Which Sociodemographic and Clinical Factors Could Influence It? A Preliminary Study.
Behav Sci (Basel)
Baldelli I, Gari M, Aguglia A, Amerio A, Berrino V, Santori G, Friedman D, Serafini G, Amore M, Raposio E.
PMID: 35049620 [PubMed - as supplied by publisher]

Drug Delivery Based on Stimuli-Responsive Injectable Hydrogels for Breast Cancer Therapy: A Review.
Xin H, Naficy S.
PMID: 35049580 [PubMed - as supplied by publisher]

Risk of breast cancer in men in relation to weight change: a national case-control study in England and Wales.
Int J Cancer
Swerdlow AJ, Bruce C, Cooke R, Coulson P, Schoemaker MJ, Jones ME.
PMID: 35049043 [PubMed - as supplied by publisher]

Breast Cancer Risk and Human Papillomavirus Infection: A Bradford Hill Criteria Based Evaluation.
Infect Disord Drug Targets
Usman M, Hameed Y, Ahmad M, Jalil Ur Rehman, Ahmed H, Hussain MS, Asif R, Murtaza MG, Jawad MT, Iqbal MJ.
PMID: 35048811 [PubMed - as supplied by publisher]

The Association between Consumption of Dairy-Originated Digestion Resistant and Bioactive Peptides and Breast Cancer Risk: A Case-Control Study.
Nutr Cancer
Jabbari M, Barati M, Shabani M, Kazemian E, Khalili-Moghadam S, Javanmardi F, Hatami E, Zeinalian R, Davoodi SH, Rashidkhani B, Jafarzadeh S, Huseyn E, Mousavi Khaneghah A.
PMID: 35048753 [PubMed - as supplied by publisher]

Breast cancer circulating tumor cells with mesenchymal features-an unreachable target?
Cell Mol Life Sci
Topa J, Gre, , Markiewicz A.
PMID: 35048186 [PubMed - in process]

Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer.
Front Cell Dev Biol
Guyot B, Lefort S, Voeltzel T, PÚcheur EI, Maguer-Satta V.
PMID: 35047500 [PubMed]

Multimodal Imaging of Target Detection Algorithm under Artificial Intelligence in the Diagnosis of Early Breast Cancer.
J Healthc Eng
Jiang M, Lei S, Zhang J, Hou L, Zhang M, Luo Y.
PMID: 35047160 [PubMed - in process]

Clinico-pathological relationship between androgen receptor and tumour infiltrating lymphocytes in triple negative breast cancer.
Elghazawy H, Bakkach J, Helal T, Aref AM, Kelany M, Abdallah LE, Abdelbakey FS, Ali D, Ali DZ, Ahmed MO, El-Hafeez AAA, Ghosh P, Alorabi MO.
PMID: 35047068 [PubMed]

Clinical Effectiveness and Safety of Chinese Herbal Medicine Compound Kushen Injection as an Add-On Treatment for Breast Cancer: A Systematic Review and Meta-Analysis.
Evid Based Complement Alternat Med
Lai BY, Chu AJ, Yu BW, Jia LY, Fan YY, Liu JP, Pei XH.
PMID: 35047051 [PubMed]

Influence of Psychological Factors in Breast and Lung Cancer Risk - A Systematic Review.
Front Psychol
Pereira MA, Ara˙jo A, Sim§es M, Costa C.
PMID: 35046872 [PubMed]

Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review.
Breast Cancer (Dove Med Press)
Maqbool M, Bekele F, Fekadu G.
PMID: 35046722 [PubMed]

Central Nervous System Metastases from Triple-Negative Breast Cancer: Current Treatments and Future Prospective.
Breast Cancer (Dove Med Press)
Kadamkulam Syriac A, Nandu NS, Leone JP.
PMID: 35046721 [PubMed]

   Articles 1 - 20 / 253099    Page 1 of 12655  Previews Next

Rect Bottom
Adserver Footer





Forgot your username or password?


New User? Sign Up

Register to My Medline!


Learn more about the My Medline experience

more >>

  Time frame  

Sky right 1